Transgene Biotek shareholders and shareholding pattern
BSE: 526139Healthcare ServicesSmall Cap
Last close ₹2.57up ₹0.20 (8.44%)
Share price at the BSE close on 23 Oct 2026. Previous close ₹2.37.
52-week range of traded prices to 23 Oct 2026
₹1.83Low, 4 Feb 2026₹4.34High, 23 Oct 2025
- Under BSE's graded surveillance, stage 0, on the list for 22 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹19 Cr4,238th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit.
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 29 May 2026
- 2.3
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 7 Aug 2026
- −17.5%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 7 Aug 2026
- −2.6%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 29 May 2026
- 2.05
- Volume, BSEVolume. Shares traded on the last trading day.
- 26,565
Who owns Transgene Biotek, filing by filing
Per cent of all the company's shares, counting those held against depositary receipts traded abroad where a filing has them. The last ten years of filings, from Dec 2016; the latest is the filing for Sep 2026.
Sep 2026 filing
- Promoters21.68%
- Individuals and others70.04%
- Depositary receipts8.28%
Shareholding pattern, per cent, from Dec 2016
- Promoters
- Individuals and others
- Depositary receipts
| Per cent | Dec 2016Filed 17 Aug | Mar 2017Filed 22 Apr | Jun 2017Filed 29 Jul | Sep 2017Filed 22 Oct | Dec 2017Filed 17 Jan | Mar 2018Filed 25 Apr | Jun 2018Filed 18 Jul | Sep 2018Filed 17 Oct | Dec 2018Filed 18 Jan | Mar 2019Filed 22 Apr | Jun 2019Filed 22 Jul | Sep 2019Filed 5 Nov | Dec 2019Filed 17 Jan | Mar 2020Filed 17 Apr | Jun 2020Filed 9 Jul | Sep 2020Filed 10 Oct | Dec 2020Filed 1 Feb | Mar 2021Filed 19 Apr | Jun 2021Filed 12 Jul | Sep 2021Filed 11 Oct | Dec 2021Filed 19 Jan | Mar 2022Filed 17 Apr | Jun 2022Filed 8 Jul | Sep 2022Filed 21 Oct | Dec 2022Filed 21 Jan | Mar 2023Filed 26 Apr | Jun 2023Filed 14 Jul | Sep 2023Filed 15 Oct | Dec 2023Filed 10 Jan | Mar 2024Filed 20 Apr | Jun 2024Filed 10 Jul | Sep 2024Filed 18 Oct | Dec 2024Filed 20 Jan | Mar 2025Filed 19 Apr | Jun 2025Filed 24 Sep | Sep 2025Filed 11 Nov | Dec 2025Filed 12 Jan | Mar 2026Filed 13 Apr | Jun 2026Filed 15 Jul | Sep 2026Filed 4 Oct |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 21.68% | 21.68% | 21.68% | 21.68% | 21.68% | 21.68% | 21.68% | 21.68% | 21.68% | 21.68% | 21.68% | 21.68% | 21.68% | 21.68% | 21.68% | 21.68% | 21.68% | 21.68% | 21.68% | 21.68% | 21.68% | 21.68% | 21.68% | 21.68% | 21.68% | 21.68% | 21.68% | 21.68% | 21.68% | 21.68% | 21.68% | 21.68% | 21.68% | 21.68% | 21.68% | 21.68% | 21.68% | 21.68% | 21.68% | 21.68% | |
| Indian promoters | 21.68% | – | 21.68% | 21.68% | 21.68% | 21.68% | 21.68% | 21.68% | 21.68% | 21.68% | 21.68% | 21.68% | 21.68% | 21.68% | 21.68% | 21.68% | 21.68% | 21.68% | 21.68% | 21.68% | 21.68% | 21.68% | 21.68% | 21.68% | 21.68% | 21.68% | 21.68% | 21.68% | 21.68% | 21.68% | 21.68% | 21.68% | 21.68% | 21.68% | 21.68% | 21.68% | 21.68% | 21.68% | 21.68% | 21.68% |
| Foreign promoters | – | 21.68% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| Public. Every shareholder outside the promoter group, the employee trusts and the shares held against depositary receipts, as the filing totals them. | 70.04% | 70.04% | 70.04% | 70.04% | 70.04% | 70.04% | 70.04% | 70.04% | 70.04% | 70.04% | 70.04% | 70.04% | 70.04% | 70.04% | 70.04% | 70.04% | 70.04% | 70.04% | 70.04% | 70.04% | 70.04% | 70.04% | 70.04% | 70.04% | 70.04% | 70.04% | 70.04% | 70.04% | 70.04% | 70.04% | 70.04% | 70.04% | 70.04% | 70.04% | 70.04% | 70.04% | 70.04% | 70.04% | 70.04% | 70.04% |
| Depositary receipts | 8.28% | 8.28% | 8.28% | 8.28% | 8.28% | 8.28% | 8.28% | 8.28% | 8.28% | 8.28% | 8.28% | 8.28% | 8.28% | 8.28% | 8.28% | 8.28% | 8.28% | 8.28% | 8.28% | 8.28% | 8.28% | 8.28% | 8.28% | 8.28% | 8.28% | 8.28% | 8.28% | 8.28% | 8.28% | 8.28% | 8.28% | 8.28% | 8.28% | 8.28% | 8.28% | 8.28% | 8.28% | 8.28% | 8.28% | 8.28% |
| Shares in issue | 7,57,70,000 | 7,57,70,000 | 7,57,70,000 | 7,57,70,000 | 7,57,70,000 | 7,57,70,000 | 7,57,70,000 | 7,57,70,000 | 7,57,70,000 | 7,57,70,000 | 7,57,70,000 | 7,57,70,000 | 7,57,70,000 | 7,57,70,000 | 7,57,70,000 | 7,57,70,000 | 7,57,70,000 | 7,57,70,000 | 7,57,70,000 | 7,57,70,000 | 7,57,70,000 | 7,57,70,000 | 7,57,70,000 | 7,57,70,000 | 7,57,70,000 | 7,57,70,000 | 7,57,70,000 | 7,57,70,000 | 7,57,70,000 | 7,57,70,000 | 7,57,70,000 | 7,57,70,000 | 7,57,70,000 | 7,57,70,000 | 7,57,70,000 | 7,57,70,000 | 7,57,70,000 | 7,57,70,000 | 7,57,70,000 | 7,57,70,000 |
| Shares underlying depositary receipts | 62,70,000 | 62,70,000 | 62,70,000 | 62,70,000 | 62,70,000 | 62,70,000 | 62,70,000 | 62,70,000 | 62,70,000 | 62,70,000 | 62,70,000 | 62,70,000 | 62,70,000 | 62,70,000 | 62,70,000 | 62,70,000 | 62,70,000 | 62,70,000 | 62,70,000 | 62,70,000 | 62,70,000 | 62,70,000 | 62,70,000 | 62,70,000 | 62,70,000 | 62,70,000 | 62,70,000 | 62,70,000 | 62,70,000 | 62,70,000 | 62,70,000 | 62,70,000 | 62,70,000 | 62,70,000 | 62,70,000 | 62,70,000 | 62,70,000 | 62,70,000 | 62,70,000 | 62,70,000 |
A dash is a line the filing did not state. “Under 0.01%” is a holding of shares too small to show at two decimals.
Transgene Biotek promoters
Promoters are the founders, families and companies that control the company, as its filings name them. Every member of the promoter group holding shares in the filing for Sep 2026; the largest is DR K KOTESWARA RAO, 20.08%.
| Holder | |||
|---|---|---|---|
| DR K KOTESWARA RAOIndividuals and Hindu undivided families | 20.08% | 1,52,11,902 | 52,11,902 |
| KOLLIPARA NIRMALAIndividuals and Hindu undivided families | 1.57% | 11,92,000 | 11,92,000 |
| KOLLIPARA SRINIVASIndividuals and Hindu undivided families | 0.03% | 24,000 | 24,000 |
No promoter shares are reported as pledged. In demat is the part of the holding kept electronically; the rest is paper certificates.